Notice for delandistrogene moxeparvovec (Roche Products Pty Ltd)
Active ingredients
delandistrogene moxeparvovec
Sponsor
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Intravenous infusion
Indication
Treatment of Duchenne muscular dystrophy
Therapeutic area
Musculoskeletal